Author

T. Karadimitriou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. N. Forbes· 1 shared A. Palladino· 1 shared D. Keifenheim· 1 shared D. Xu· 1 shared E. Khurana· 1 shared I. Gallego-Lopez· 1 shared L. Guerrero Negron· 1 shared M. Pickering· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. N. Forbes

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Post-Transcriptional Size-Dependent Expression of the Fission Yeast Cdc13 Cyclin

S. Bashir, X.-M. Sun, Y. Zhao, N. G. Martinez-Illescas, I. Gallego-Lopez, L. Guerrero Negron, D. Keifenheim, T. Karadimitriou, M. Pickering, S. Marguerat, N. Rhind

This study shows that Cdc13 in fission yeast is size-dependent at the protein level but not at the mRNA level, and identifies a motif responsible for this regulation, demonstrating it is not essential for size control.

bioRxiv · Jan 16, 2023 · PreprintCell Biology

Recapitulation of patient-specific 3D chromatin conformation using machine learning and validation of identified enhancer-gene targets

D. Xu, A. N. Forbes, S. Cohen, A. Palladino, T. Karadimitriou, E. Khurana

The paper develops a machine learning model to predict enhancer-gene connections from ATAC-seq and RNA-seq data, validated using multi-omics data and CRISPRi in cancer patients.

bioRxiv · Nov 16, 2021 · PreprintCancer Biology